Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis

2014/11/01 by Anne M Selvaag, Anne M. Selvaag, Hanne A Aulie +3 · 230 citations
Health Professions · Medicine · #Adolescent and Pediatric Healthcare #Arthritis #Autoimmune and Inflammatory Disorders Research #Cohort #Disease #Erythrocyte sedimentation rate #Internal medicine #Juvenile #Juvenile rheumatoid arthritis #Medicine #Pediatrics #Physical therapy #Rheumatoid Arthritis Research and Therapies #Rheumatology

paper · doi:10.1136/annrheumdis-2014-206034

published in Annals of the Rheumatic Diseases 75(1), 190-195 (BMJ)

openalex publication_date 2014/11/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Citations

• Ongoing disease activity and changing categories in a long‐term nordic cohort study of juvenile idiopathic arthritis
• Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

Cited by

• Juvenile Idiopathic Arthritis in Olmsted County, Minnesota, 1960-2013. [europepmc]
• Premature subclinical atherosclerosis in children and young adults with juvenile idiopathic arthritis. A review considering preventive measures. [europepmc]
• Improving care delivery and outcomes in pediatric rheumatic diseases. [europepmc]
• Analysis of health care claims during the peri-transfer stage of transition from pediatric to adult care among juvenile idiopathic arthritis patients. [europepmc]
• How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definition. [europepmc]
• A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities. [europepmc]
• Transitional care for rheumatic conditions in Europe: current clinical practice and available resources. [europepmc]
• Developing and Evaluating JIApp: Acceptability and Usability of a Smartphone App System to Improve Self-Management in Young People With Juvenile Idiopathic Arthritis. [europepmc]
• Review: Genetics and the Classification of Arthritis in Adults and Children. [europepmc]
• Patterns of pain over time among children with juvenile idiopathic arthritis. [europepmc]
• Barriers to Adherence in Juvenile Idiopathic Arthritis: A Multicenter Collaborative Experience and Preliminary Results. [europepmc]
• Untimely illness: When diagnosis does not match age-related expectations. [europepmc]
• Participation in school and physical education in juvenile idiopathic arthritis in a Nordic long-term cohort study. [europepmc]
• Transitional Care in Rheumatology: a Review of the Literature from the Past 5 Years. [europepmc]
• Outcome in juvenile idiopathic arthritis: a population-based study from Sweden. [europepmc]
• Timing matters: real-world effectiveness of early combination of biologic and conventional synthetic disease-modifying antirheumatic drugs for treating newly diagnosed polyarticular course juvenile idiopathic arthritis. [europepmc]
• Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a two-centre experience. [europepmc]
• Prevalence of co-existing autoimmune disease in juvenile idiopathic arthritis: a cross-sectional study. [europepmc]
• Subclinical cardiovascular risk signs in adults with juvenile idiopathic arthritis in sustained remission. [europepmc]
• Fatigue in young adults with juvenile idiopathic arthritis 18 years after disease onset: data from the prospective Nordic JIA cohort. [europepmc]
• Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. [europepmc]
• Frequency of juvenile idiopathic arthritis and associated uveitis in pediatric rheumatology clinics in Turkey: A retrospective study, JUPITER. [europepmc]
• Health-related quality of life and disability in adults with juvenile idiopathic arthritis: comparison with adult-onset rheumatic diseases. [europepmc]
• Discontinuation of biologic DMARDs in non-systemic JIA patients: a scoping review of relapse rates and associated factors. [europepmc]
• Joint-specific memory, resident memory T cells and the rolling window of opportunity in arthritis. [europepmc]